Attached files

file filename
EX-31.2 - EX-31.2 - BIOADAPTIVES, INC.ex-31_2.htm
EX-32.1 - EX-32.1 - BIOADAPTIVES, INC.ex-32_1.htm
10-K - FORM 10-K - BIOADAPTIVES, INC.2015-12-31-bdpt_10k.htm
EX-31.1 - EX-31.1 - BIOADAPTIVES, INC.ex-31_1.htm
 

EXHIBIT 32.2

 

 

 

BioAdaptives Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO SECTION 906 OF 

THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of BioAdaptives Inc. (the Registrant) on Form 10-K for the period ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Christopher G. Hall, Principal Financial Officer of the Company, certify,  pursuant to 18 U.S.C.  ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  

(1)  The Report fully complies with the  requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

A signed original of this written statement required by Section 906 has been provided to Christopher G. Hall, and will be retained by BioAdaptives Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

  

 

Dated: April 14, 2016 

 

 

By: /s/ Christopher G. Hall

Christopher G. Hall

Chief Financial Officer 

(Principal Financial Officer)